BioCentury
ARTICLE | Clinical News

Hemopure bovine hemoglobin glutamer: Phase III trial update

January 17, 2000 8:00 AM UTC

Biopure Corp. (BPUR), Cambridge, Mass. Product: Hemopure bovine hemoglobin glutamer Business: Blood products/substitutes Therapeutic category: Blood substitute Target: NA Description: Ultrapurified cr...